With the passage of New Jersey’s cannabis reform legislation, Rowan University announced the formation of a new interdisciplinary research institute to assist and advise policy makers, health care professionals, pharmaceutical industries, government agencies and businesses.
The Rowan University Institute for Cannabis Research, Policy & Workforce Development provides expertise and guidance on a wide variety of topics including law, medicine, chemistry, pharmacology and business. Rowan will also conduct research to help fully understand the impact of New Jersey’s cannabis laws, as well as the potential medicinal uses of cannabinoid compounds. All research activities will be conducted in accordance with federal law and under the strict guidance of the Office of Research Compliance.
“New Jersey is entering a whole new world,” said President Ali A. Houshmand, Ph.D. “Rowan University has the expertise and resources necessary to study the potential medicinal uses of cannabis, as well as the societal impacts of these new laws. The research possibilities are endless.”
The institute is focused on three key areas:
“Interdisciplinary collaboration is critically needed to help understand how these new cannabis laws will affect New Jersey,” said Tabbetha Dobbins, Ph.D., interim vice president for research at Rowan University. “We’ve seen the impact on other states and the possibilities. Research and data will be necessary to help us navigate this monumental shift in our society.”
To access more business news, visit NJB News Now.Related Articles: